Evidence map›Paper›PMID 32784552›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Active Pulmonary Tuberculosis in Elderly Patients: A 2016-2019 Retrospective Analysis from an Italian Referral Hospital.

Francesco Di Gennaro, Pietro Vittozzi, Gina Gualano, Maria Musso, Silvia Mosti, Paola Mencarini, Carlo Pareo, Antonino Di Caro, Vincenzo Schininà, Enrico Girardi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Abnormal Liver Function at the Time of Tuberculosis Diagnosis in South India.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2026
    Article
  7. Prevalence ofIJID regions · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Francesco Di GennaroRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.ORCID 0000-0003-3453-5647
Pietro VittozziRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Gina GualanoRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Maria MussoRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Silvia MostiRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Paola MencariniRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Carlo PareoRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Antonino Di CaroMicrobiology and Bio-Repository Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.ORCID 0000-0001-6027-3009
Vincenzo SchininàDiagnostic Imaging Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Enrico GirardiClinical Epidemiology Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Fabrizio PalmieriRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) in the elderly (>65 years old) has increasingly become a global health problem. It has long been recognized that older people are vulnerable to developing tuberculosis. We retrospectively evaluated data from patients older than 65 years diagnosed with pulmonary TB admitted to the National Institute for Infectious Diseases L. Spallanzani, Rome, Italy, from 1 January 2016 to 31 December 2019. One hundred and six consecutive patients were diagnosed with pulmonary TB and 68% reported at least one comorbidity and 44% at least one of the TB risk-factors. Out of the 26 elderly patients who reported an adverse event, having risk factors for TB (O.R. (Odds Ratios) = 1.45; 95% CI 1.12-3.65) and the presence of cavities on Chest X-rays (O.R. = 1.42; 95% CI 1.08-2.73) resulted in being more likely to be associated with adverse events in elderly patients. Having weight loss (O.R. = 1.31; 95% CI 1.08-1.55) and dyspnea (O.R. = 1.23; 95% CI 1.13-1.41) resulted in being significant predictors of unsuccessful treatment outcome in elderly patients. Older people with TB represent a vulnerable group, with high mortality rate, with a challenging diagnosis. Hospitalizations in tertiary referral hospital with clinical expertise in TB management can be useful to improve the outcome of these fragile patients.

Indexed as

adverse eventselderlyoutcomerisk factorstuberculosis (TB)

Identifiers

PMID32784552
PMCPMC7459440
OpenAlexW3047114834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.